Saga Itäinen-Strömberg

4PUBLICATIONS
17CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 04, 2025
How much does elective cardioversion increase the risk of ischaemic stroke compared to the baseline risk in atrial fibrillation? A nationwide study.

Saga Itäinen-Strömberg, Mika Lehto, Olli Halminen

|Jun 14, 2024
Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation: a Nationwide Cohort Study.

Mika Lehto, Alex Luojus, Olli Halminen

|Jun 03, 2024
Thromboembolic and bleeding complications after elective cardioversion of atrial fibrillation: a nationwide cohort study.

Saga Itäinen-Strömberg, Mika Lehto, Olli Halminen

|Apr 30, 2020
Real-life experience with non-vitamin K antagonist oral anticoagulants versus warfarin in patients undergoing elective cardioversion of atrial fibrillation.

Saga Itäinen-Strömberg, Anna-Mari Hekkala, Aapo L Aro

Pageof 1

Frequent Collaborators

3 joint publications

Mika Lehto

3 joint publications

Olli Halminen

3 joint publications

Jukka Putaala

3 joint publications

Jari Haukka